Watertown, Mass, July 9, 2024 – Exergen Corporation, a pioneer in infrared thermometry technology, announces its receipt of approval from Peruvian regulatory authorities to introduce its comprehensive range of Temporal Artery Thermometers to the Peruvian market. The DIGEMID approval confirms that all Exergen thermometers comply with the rigorous standards for accuracy, reliability, and safety as mandated by the Peruvian government.
The approved product line includes the TAT-5000S, designed specifically for hospital use, the TAT-2000 for lightweight clinical applications, and the TAT-2000C for consumer use at home. These approvals mark a significant milestone for Exergen as it expands its global footprint.
Eduardo Felipe Herrera Medina, General Manager of Diagnostico Medico Sac, the official distributor for Exergen in Peru, expressed his enthusiasm about the approval. “We are thrilled to now be able to support hospitals and healthcare facilities throughout Peru with Exergen’s Temporal Artery Thermometers. Their proven accuracy and ease of use not only enhance clinical care but also increase operational productivity within medical settings.”
Dr. Francesco Pompei, founder and CEO of Exergen Corporation, shared his vision for the impact this expansion will have on healthcare in Peru. “We are delighted to bring our trusted thermometers to Peruvian medical professionals and households. Our goal is to assist in improving the healthcare services available to doctors, nurses, and parents in Peru, ensuring that patient care is both effective and efficient.”
About Exergen
Exergen Corporation, headquartered in Watertown, Massachusetts, United States, is the leader in non-invasive temperature measurement technologies for industrial and medical applications, and delivers non-invasive temperature meters with higher accuracy, lower costs, less process control, and higher reliability than previously possible. Known in both healthcare and consumer markets for its award-winning arterial thermometer, Exergen was founded by MIT and Harvard graduate, and Harvard research scientist, Dr. Francesco Pompei, who is inventor of more than 100 patents owned by Exergen.
Media contact
Christina Guilbert
cguilbert@exergen.com
EXERGEN P/N 850158, Rev 1